CityMD / Summit Health Credit Rating & NNN Cap Rate Analysis

CityMD / Summit Health Business Overview & NNN Investment Profile

CityMD is one of the largest urgent care operators in the New York City metropolitan area, with approximately 150 walk-in clinics across Manhattan, Brooklyn, Queens, the Bronx, Staten Island, Long Island, and northern New Jersey. Summit Health is a multispecialty physician group operating over 200 additional locations primarily across New Jersey, New York, Connecticut, Pennsylvania, and Central Oregon. The two brands merged in 2019 and were subsequently acquired by VillageMD for $8.9 billion in early 2023. VillageMD was majority-owned by Walgreens Boots Alliance, which invested $3.5 billion to support the acquisition.

The ownership structure has changed dramatically since then. In August 2025, Sycamore Partners completed its $23.7 billion leveraged buyout of Walgreens Boots Alliance, taking the entire company private. As part of the restructuring, VillageMD (including CityMD and Summit Health) was separated to operate as a standalone private company. This means NNN investors holding CityMD or Summit Health leases are now dealing with a private-equity-owned healthcare platform that has no public credit rating, no public financial reporting, and a history of operating losses under its previous corporate parent.

Why CityMD / Summit Health Has NNN Investment Relevance

Despite the ownership turbulence, CityMD and Summit Health occupy prime real estate in one of the most valuable healthcare markets in the world. New York City urgent care clinics serve a massive, dense population with high commercial insurance penetration and strong walk-in traffic. CityMD locations are typically situated in high-foot-traffic retail corridors with excellent visibility and accessibility. The brand has strong consumer recognition in the NYC metro, and its clinics serve a mix of commercial insurance, Medicare, and self-pay patients. Summit Health’s multispecialty presence in affluent New Jersey and Connecticut suburbs adds geographic diversification and a referral network that strengthens the combined platform.

The NNN investment case here is primarily a location and re-tenanting story rather than a credit story. CityMD clinics of 3,000 to 6,000 square feet in prime NYC retail locations are among the most re-tenantable healthcare properties in the country. If VillageMD were to close or vacate any of these locations, the spaces would attract strong demand from other healthcare tenants, retail operators, or personal services businesses. Summit Health locations, often larger at 10,000 to 15,000 square feet in suburban medical office or retail settings, are similarly well-positioned for alternative medical use. Investors should evaluate each property primarily on location quality and re-tenanting potential rather than relying on the current tenant’s creditworthiness.

Cap Rate Analysis & Pricing for CityMD / Summit Health NNN Properties

CityMD / Summit Health NNN properties trade in the 7.00% to 8.50% cap rate range as of Q1 2026. The wide spread reflects uncertainty around the VillageMD ownership transition and the absence of a public credit rating. Prime CityMD locations in Manhattan or affluent suburban NYC corridors may trade toward 7.00% based on location value alone, while Summit Health locations in secondary markets or with shorter remaining terms may approach 8.50%.

Pricing typically ranges from $2 million for smaller CityMD urgent care clinics to $10 million for larger Summit Health multispecialty facilities. NYC metro healthcare real estate carries a significant location premium that partially offsets the credit risk: even at wider cap rates, the underlying real estate value in these markets provides a meaningful floor. Per-square-foot rents for CityMD locations in Manhattan and prime Brooklyn/Queens corridors can range from $60 to $120 NNN, while Summit Health suburban locations typically command $30 to $50 NNN.